Extent of Coronary and Myocardial Disease and Benefit From Surgical Revascularization in LV Dysfunction
Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Szwed H, Larbalestier R, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL. Extent of Coronary and Myocardial Disease and Benefit From Surgical Revascularization in LV Dysfunction. Journal Of The American College Of Cardiology 2014, 64: 553-561. PMID: 25104523, PMCID: PMC4129547, DOI: 10.1016/j.jacc.2014.04.064.Peer-Reviewed Original ResearchConceptsCoronary artery bypass graft surgeryOptimal medical therapyCoronary artery diseaseEnd-systolic volume indexEjection fractionSurgical revascularizationIschemic cardiomyopathyMedical therapyPrognostic factorsExtensive coronary artery diseaseArtery bypass graft surgeryIschemic left ventricular dysfunctionAdvanced ischemic cardiomyopathySubsequent survival benefitBypass graft surgeryHigh operative riskLeft ventricular dysfunctionGraft surgeryLV dysfunctionRevascularization TrialVentricular dysfunctionOperative riskSurvival benefitArtery diseaseMyocardial dysfunction